CURE’s leukemia page is a go-to resource for oncology news and updates in the world of leukemia Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in leukemia.
June 26th 2025
The FDA has granted priority review to an application for Revuforj for the treatment of relapsed or refractory mutant NPM1 acute myeloid leukemia.
FDA Approval of Jakafi for Chronic GVHD Provides Another Option, But ‘More Work Needs to Be Done’
September 29th 2021While the recent FDA approval of Jakafi offers another effective option for patients with chronic GVHD, one expert urges that more work needs to be done to prevent and/or reverse the condition.
Chronic GVHD Treatment Improves, But Is Still Far From Perfect
September 20th 2021Patients with blood cancer who underwent stem cell transplant and developed chronic graft-versus-host disease have more treatment options than ever before. But the formula for planning older and newer therapies has not yet been established.
FDA Grants Investigational Therapy Breakthrough Designation for Chronic Myeloid Leukemia
February 10th 2021The Food and Drug Administration has granted the investigational therapy asciminib a breakthrough therapy designation for the treatment of certain adults with Philadelphia chromosome-positive chronic myeloid leukemia. The designation may allow for expedited review of the drug.
FDA Approves Iclusig for Adult Patients with Resistant/Intolerant Chronic-Phase CML
December 19th 2020The Food and Drug Administration approved the supplemental new drug application for Iclusig (ponatinib) to treat patients with chronic-phase chronic myeloid leukemia (CML) with resistance or intolerance to at least two prior kinase inhibitors.
Faith, Science, and Miracles: A Conversation About CAR-T Cell Therapy with the Whitehead Family
December 4th 2020Emily Whitehead was the first child to receive chimeric antigen receptor (CAR)-T cell therapy. Eight years later, she and her parents discuss her ongoing remission from acute lymphoblastic leukemia.